Edition:
India

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

5.35USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$5.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
152,711
52-wk High
$14.09
52-wk Low
$4.91

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
FY 2015 Dec '15 3.77 -23.706
Sep '15 0.00 -4.154
Jun '15 0.00 -2.966
Mar '15 0.00 -4.981
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 6 1.40 1.80 1.00 0.57
Quarter Ending Mar-18 4 1.62 2.30 1.00 --
Year Ending Dec-17 6 5.60 6.00 5.20 3.54
Year Ending Dec-18 6 5.67 9.50 2.90 3.70
Earnings (per share)
Quarter Ending Dec-17 6 -0.57 -0.48 -0.62 -0.59
Quarter Ending Mar-18 4 -0.57 -0.48 -0.63 --
Year Ending Dec-17 5 -2.61 -2.46 -3.06 -2.74
Year Ending Dec-18 6 -2.31 -1.85 -2.86 -12.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 26 --
13 Week -20.95 -24.80 20 --
26 Week -24.27 -30.03 27 --
52 Week 15.92 -1.75 62 --
YTD 39.26 22.30 72 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.69%
# of Holders: 46
Total Shares Held: 24,835,415
3 Mo. Net Change: 4,868,743
# New Positions: 25
# Closed Positions: 8
# Increased Positions: 38
# Reduced Positions: 11
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.